Clinical trials are controlled tests of new drugs or treatments. These studies are among the fastest and safest ways to find treatments that work against pediatric cancer. Because of clinical trials, survival rates for pediatric cancers have increased to over 80 percent overall.
At the Division of Hematology/Oncology and Stem Cell Transplantation, we are always involved in the latest clinical trials, from conducting trials run by our own physicians and scientists to participating in national trials through cooperative groups such as the Children’s Oncology Group (COG).
No matter what phase a clinical trial is in, the safety of our patients is our top priority. All trials are approved by our Institutional Review Board (IRB) and monitored regularly. Keep in mind that a clinical trial may not always be the best option for you and your child, so our treatment team will discuss all the available options with you and help to determine the best plan for his or her unique case.
To learn more about our current and upcoming clinical trials, click here.
Experimental hematology and oncology
Our laboratory research programs are highly integrated with our clinical research and clinical care in order to translate scientific discovery into the prevention and cure of childhood cancer and blood diseases. There are currently five Experimental Hematology and Oncology laboratory and translational research teams that engage PhD, MD-PhD and MD scientists in teaching and research:
Central Nervous System Tumors
Les Nelkin Memorial Pediatric Oncology Laboratory